Do Treg Speed Up with CARs? Chimeric Antigen Receptor Treg Engineered to Induce Transplant Tolerance

Kaljanac, Marcell and Abken, Hinrich (2023) Do Treg Speed Up with CARs? Chimeric Antigen Receptor Treg Engineered to Induce Transplant Tolerance. LIPPINCOTT WILLIAMS & WILKINS, PHILADELPHIA.

Full text not available from this repository. (Request a copy)

Abstract

Adoptive transfer of regulatory T cells (Treg) can induce transplant tolerance in preclinical models by suppressing alloantigen-directed inflammatory responses; clinical translation was so far hampered by the low abundance of Treg with allo-specificity in the peripheral blood. In this situation, ex vivo engineering of Treg with a T-cell receptor (TCR) or chimeric antigen receptor (CAR) provides a cell population with predefined specificity that can be amplified and administered to the patient. In contrast to TCR-engineered Treg, CAR Treg can be redirected toward a broad panel of targets in an HLA-unrestricted fashion, making these cells attractive to provide antigen-specific tolerance toward the transplanted organ. In preclinical models, CAR Treg accumulate and amplify at the targeted transplant, maintain their differentiated phenotype, and execute immune repression more vigorously than polyclonal Treg. With that, CAR Treg are providing hope in establishing allospecific, localized immune tolerance in the long term, and the first clinical trials administering CAR Treg for the treatment of transplant rejection are initiated. Here, we review the current platforms for developing and manufacturing alloantigen-specific CAR Treg and discuss the therapeutic potential and current hurdles in translating CAR Treg into clinical exploration.

Item Type: Other
Uncontrolled Keywords: REGULATORY T-CELLS; VERSUS-HOST-DISEASE; KIDNEY-TRANSPLANTATION; ALLOGRAFT-REJECTION; DONOR LYMPHOCYTES; GENE-TRANSFER; TR1 CELLS; THERAPY; EXPRESSION; FOXP3;
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Zentren des Universitätsklinikums Regensburg > Regensburger Centrum für Interventionelle Immunologie (RCI)
Depositing User: Dr. Gernot Deinzer
Date Deposited: 19 Mar 2024 06:31
Last Modified: 19 Mar 2024 06:31
URI: https://pred.uni-regensburg.de/id/eprint/59526

Actions (login required)

View Item View Item